Rifampicin-induced nephrotoxicity in a tuberculosis patient

by Alexandria Beebe, Barbara Seaworth, Naveen Patil
Published 2015-11-01

Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018

by Ashley McDowell, Michelle Haas, Barbara Seaworth, John W. Wilson, Amee Patrawalla, Connie Haley, Mike Lauzardo, Miko de Bruyn, Neela D. Goswami
Published 2021-02-01

Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives

by Erica Lessem, Helen Cox, Colleen Daniels, Jennifer Furin, Lindsay McKenna, Carole D. Mitnick, Thato Mosidi, Caitlin Reed, Barbara Seaworth, Jonathan Stillo, Phumeza Tisile, Dalene von Delft
Published 2015-03-01

Tuberculosis Regional Training and Medical Consultation Centers in the United States: Characteristics, outcomes, and quality of medical consultations, June 1, 2010 — May 31, 2014

by Sundari R. Mase, Ratima Samron, David Ashkin, Kenneth G. Castro, Stephen Ryan, Barbara Seaworth, Lisa Chen, Alfred Lardizabal, Dawn Tuckey, Amera Khan, Drew L. Posey, Courtney Chappelle, Zelalem Temesgen
Published 2019-12-01

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007

by Suzanne M. Marks, Jennifer Flood, Barbara Seaworth, Yael Hirsch-Moverman, Lori Armstrong, Sundari Mase, Katya Salcedo, Peter Oh, Edward A. Graviss, Paul W. Colson, Lisa Armitige, Manuel Revuelta, Kathryn Sheeran
Published 2014-05-01

Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

by Carole D Mitnick, Carly A Rodriguez, Marita L Hatton, Grania Brigden, Frank Cobelens, Martin P Grobusch, Robert Horsburgh, Christoph Lange, Christian Lienhardt, Eyal Oren, Laura J Podewils, Barbara Seaworth, Susan van den Hof, Charles L Daley, Agnes C Gebhard, Fraser Wares, RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative)
Published 2016-01-01